An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors

NCT06094556 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-1826

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.